★ Sign in to follow
AL

Anders Lundberg

SE·Finansinspektionen
Prostatype Genomics AB
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
21
Company
1
▲ Purchases (10 ops.)
€46k
▼ Sales (3 ops.)
€3,608

Latest filing published 18 Sept 2026 for Prostatype Genomics AB, €2,044.

Filing timeline

BuySale
Anders Lundberg

Insider track record

Disclosed buys
10
Disclosed sells
3
Signal history

Closed purchases

Market purchases
10

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Anders Lundberg: trading record in brief

Anders Lundberg is a declared insider of Prostatype Genomics AB, with filings sourced from Finansinspektionen. The record holds 21 filings, for trades running from 3 November 2020 to 18 September 2026.

Both buying and selling appear: 10 purchases worth €46k, against 3 sales worth €3,608. Netting one side against the other leaves €43k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 2 purchases and no sales.

A typical purchase (the median) is worth €3,805.

The newest entry dates from 18 September 2026: an open-market purchase of €2,044, in Prostatype Genomics AB. Typically, a trade is published a median of 1 day after it takes place. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Anders Lundberg

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ▲
    Anders Lundberg
    StyrelseledamotExecutivesProstatype Genomics AB
    23,220 SEK0FI-SE
    380,660 shares@ SEK 0.0612.9% of flowTeckningsoptionISIN SE0029529783FI:csv-d6a50daa68917d7cdae2
    Canonical exit: 17 Dec 2026 (T+90)
  • ●
    Anders Lundberg
    StyrelseledamotExecutivesProstatype Genomics AB
    0FI-SE
    1,287,500 shares0TeckningsoptionISIN SE0029529767FI:csv-c619d63e594e345d7032
  • ●
    Anders Lundberg
    StyrelseledamotExecutivesProstatype Genomics AB
    128,750 SEK21FI-SE
    1,287,500 shares@ SEK 0.100.67% mcap15.9% of flowInterimsaktieISIN SE0030262895FI:csv-bffeb2b463228f929877
  • ▲
    Anders Lundberg
    StyrelseledamotExecutivesProstatype Genomics AB
    28,000 SEK0FI-SE
    500,000 shares@ SEK 0.0560.6% of flowOptionISIN SE0029529783FI:csv-a4525078569cf2c20a2f
    Canonical exit: 9 Dec 2026 (T+90)
  • ●
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    250,000 SEK0FI-SE
    62,500 shares@ SEK 4.00BTU (betald tecknad unit)ISIN SE0024990089FI:csv-22eaf35e8e80a6e64703
  • ●
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    1M SEK9FI-SE
    106,931,000 shares@ SEK 0.0123.3% of flowAktieISIN SE0014684569FI:csv-e30f355729659b121558
  • ●
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    1M SEK0FI-SE
    21,386,190 shares@ SEK 0.0523.1% of flowBTU (betald tecknad unit)ISIN SE0022574570FI:csv-e64ac26394a5978b9098
  • ▼
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    2,043 SEK7FI-SE
    97,283 shares@ SEK 0.0210.0% of flowAktieISIN SE0014684569FI:csv-3e8c7398142625ce3292
  • ▼
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    11,152 SEK7FI-SE
    464,653 shares@ SEK 0.0240.2% of flowAktieISIN SE0014684569FI:csv-35a4f4b899714cb23342
  • ▼
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    27,916 SEK7FI-SE
    1,187,913 shares@ SEK 0.02350.6% of flowAktieISIN SE0014684569FI:csv-518d805f8611d3076fe8
  • ●
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    200,000 SEK7FI-SE
    5,000,000 shares@ SEK 0.044.2% of flowAktieISIN SE0014684569FI:csv-af77d2305b9f61fb42b8
  • ●
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    500,000 SEK0FI-SE
    1,250,000 shares@ SEK 0.4011.0% of flowBTU (betald tecknad unit)ISIN SE0018245425FI:csv-d5303f5bfea1104522c0
  • ●
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    832,755 SEK0FI-SE
    3,331,020 shares@ SEK 0.2518.1% of flowBTA (betald tecknad aktie)ISIN SE0020179430FI:csv-c2b5329f288900a95cf3
  • ▲
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    40,200 SEK19FI-SE
    20,000 shares@ SEK 2.010.9% of flowAktieISIN SE0014684569FI:csv-540af8c0cc734fc15477
    Canonical exit: 8 Feb 2023 (T+90)
  • ▲
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    42,400 SEK19FI-SE
    20,000 shares@ SEK 2.121.0% of flowAktieISIN SE0014684569FI:csv-8d8eb5149e67ce87e8a7
    Canonical exit: 9 Feb 2023 (T+90)
  • ▲
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    46,475 SEK0FI-SE
    5,000 shares@ SEK 9.295AktieISIN SE0014684569FI:csv-34d645962b44d1e8dcb5
    Canonical exit: 27 Feb 2022 (T+90)
  • ▲
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    99,610 SEK0FI-SE
    10,000 shares@ SEK 9.961AktieISIN SE0014684569FI:csv-8b5eed0002bda3235a52
    Canonical exit: 20 Feb 2022 (T+90)
  • ▲
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    69,872 SEK0FI-SE
    4,400 shares@ SEK 15.88AktieISIN SE0014684569FI:csv-e5ea027bb4ff819a4bc3
    Canonical exit: 1 Dec 2021 (T+90)
  • ▲
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    7,500 SEK0FI-SE
    1,000 shares@ SEK 7.50AktieISIN SE0014684569FI:csv-753e9708c086088f1b93
    Canonical exit: 1 Feb 2021 (T+90)
  • ▲
    Anders Lundberg
    StyrelseordförandeExecutivesProstatype Genomics AB
    25,000 SEK0FI-SE
    2,000 shares@ SEK 12.50AktieISIN SE0014684569FI:csv-771cf1da30e3d3f20ea7
    Canonical exit: 30 May 2021 (T+90)

20 of 20 declarations

Related entities

No related entities found.